Re: Vas. Dementia pipeline RVX?
|
4
|
Resverlogix Corp.
|
Dec 06, 2022 05:23PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
3
|
Resverlogix Corp.
|
Nov 14, 2022 06:20PM
|
Re: Teflon Don
|
4
|
Zenith Epigenetics
|
Nov 02, 2022 11:21AM
|
Re: I followed up with Chris ..
|
1
|
Resverlogix Corp.
|
Oct 27, 2022 03:49PM
|
Re: no web cast - from IR
|
2
|
Zenith Epigenetics
|
Oct 27, 2022 10:57AM
|
Re: I followed up with Chris ..
|
5
|
Resverlogix Corp.
|
Oct 27, 2022 10:44AM
|
Re: Recent Funding - Zenith CC
|
1
|
Zenith Epigenetics
|
Oct 24, 2022 07:38AM
|
Re: Another Week
|
4
|
Resverlogix Corp.
|
Oct 21, 2022 07:05PM
|
Another Week
|
5
|
Resverlogix Corp.
|
Oct 21, 2022 02:06PM
|
Re: Fun with Numbers
|
2
|
Resverlogix Corp.
|
Oct 18, 2022 02:52PM
|
CEO Compensation
|
2
|
Zenith Epigenetics
|
Oct 18, 2022 02:07PM
|
CEO Compensation
|
9
|
Resverlogix Corp.
|
Oct 18, 2022 02:05PM
|
Re: AGM Voting
|
6
|
Zenith Epigenetics
|
Oct 18, 2022 12:25PM
|
Fun with Numbers
|
5
|
Resverlogix Corp.
|
Oct 18, 2022 11:13AM
|
AGM Voting
|
5
|
Zenith Epigenetics
|
Oct 16, 2022 10:37AM
|
Re: Sept 30 2022 - Resverlogix streaming video
|
4
|
Resverlogix Corp.
|
Sep 30, 2022 08:37AM
|
Re: Latest on COVID-19
|
3
|
Resverlogix Corp.
|
Sep 29, 2022 06:35PM
|
Re: Latest on COVID-19
|
7
|
Resverlogix Corp.
|
Sep 29, 2022 11:46AM
|
Re: Latest on COVID-19
|
5
|
Resverlogix Corp.
|
Sep 28, 2022 09:37AM
|
Re: No news, did you expect a change
|
5
|
Resverlogix Corp.
|
Sep 22, 2022 04:46PM
|